Schedule 13G ownership disclosure

Celldex Therapeutics, Inc.

Security class unavailable · CUSIP: 15117B103

Event date: 2016-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-789419
Form type
SC 13G
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Dec 09, 2016
Reporting period
Nov 29, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub